Series A Showcase Presenters
Augment Health, Inc.
Augment Health, Inc. is developing a noninvasive bladder monitor + AI algorithm for patients with NLUTD. Today's in-clinic diagnostics face a 44% failure rate and limited access for 7M patients. Our at-home device improves pressure data reliability with proprietary AI analysis, reducing specialist burden and improving access. Learn More
Cystotech
Cystotech is dedicated to transforming the clinical pathway for bladder cancer patients worldwide. Our innovative AI-driven software provides clinicians with real-time decision support during Cystoscopy, aiming to enhance patient outcomes. We strive to improve the quality of life for bladder cancer patients while reducing the financial burden on healthcare providers and payers. Learn More
DeepQure
"DeepQure is pioneering the HyperQure™ RDN System, an investigational, minimally invasive, extravascular renal denervation technology for resistant hypertension that enables circumferential renal sympathetic nerve ablation. Multicenter studies in Korea and the U.S. are ongoing to evaluate its safety and efficacy." Learn More
EndoTheia, Inc
At EndoTheia, we aim to harness the power of intelligently micro-machined smart materials to create highly dexterous manipulators at millimeter and sub-millimeter scales to improve therapeutic outcomes in complex flexible endoscopic procedures. The devices we are creating serve as adjuncts to standard, widely-used, and commercially-available endoscopic tools to augment performance and improve quality of care with minimal workflow disruption. Learn More
ImmunoPDT Ltd
A T-Cell mediated immune response to the patient's Prostate Cancer is created while the Photo Dynamic Therapy (PDT) treatment kills the whole of the cancer in the gland. Learn More
Insight Medbotics
Insight Medbotics is developing MRI-compatible robotics, a new category of robotics designed to solve MRI access for urologists across care settings and revolutionize precision in prostate cancer care. Learn More
MEDiThings Co., Ltd.
MEDiThings, an AI healthcare startup from South Korea, pioneers wearable biosensing technology. MEDiThings develops non-invasive urology solutions using a NIRS-centered platform with integrated sensing technologies. Our system provides real-time bladder information that helps individuals manage urinary health. Learn More
Nowwell
Nowwell is a Medtech company developing next-generation catheters. We enhance patient care and help ensure that incontinence and retention no longer limit lives. Learn More
ProArc
ProArc Medical is an interventional urology company developing a patented self-embedding implant for BPH-related LUTS. Interim multicenter pilot study results show significant, above-expected IPSS improvement and fast post-procedure recovery. Learn More
Relief S.r.l.
Relief S.r.l. is a medtech startup focused on transforming the treatment of stress urinary incontinence with a minimally invasive, removable and reversible solution, while preserving anatomy and patient quality of life. Learn More
Stimuli Technology
Born out of a vision to develop non-invasive and non-drug therapeutic solutions, Stimuli Technology focuses on overactive bladder with Tensi+ MD. This patient-friendly and clinically proven electrostimulation solution reduces OAB symptoms and improves patients’ quality of life. Learn More
SurgeXplain
SurgeXplain is an AI-powered patient companion that delivers personalized, interactive education across the entire healthcare journey, improving patient understanding and satisfaction while reducing physician workload, burnout, and barriers to high-quality care. Learn More
Tricol Biomedical Inc
Tricol Biomedical is a medical device company with the mission to significantly reduce patient morbidity and achieve zero preventable deaths due to blood loss. The blood stops here. Learn More
VersaWell
VersaWell an emerging healthcare company provides innovative solutions for healthier living. Launching UriGent the first in the world bedside portable urinal for men is a safer, more convenient and dignified alternative for managing personal hygiene and preventing falls associated with dangerous walks to the bathroom at night.
Virchow Medical, Inc.
We allow hospitals to unlock critical molecular data for every cancer patient, enabling precision medicine to save more lives, while building a unique liquid specimen biorepository that generates testing volume for clinical labs and data for targeted therapy development. Learn More
Virtuoso Surgical, Inc.
Virtuoso has developed a groundbreaking robotic surgery system featuring 1-millimeter instruments for rigid endoscopic procedures, providing surgeons with unprecedented two-handed control and dexterity. Their device was recently designated a breakthrough device by FDA for intact removal of bladder tumors. Learn More
Watershed Therapeutics
Watershed Medical is a clinical-stage drug company developing intravesical combination products for bladder cancer. Its platform enables delivery of multiple therapies in a comfortable, bladder-retentive format with passive, non-procedural clearance. Learn More
Xaga Surgical
Xaga Surgical’s Forsvall needle—now in clinical use in the US—aims to raise the standard for TR and TP biopsy with excellent cores, superior targeting and a 96% reduction in bacterial transfer. Designed to address diagnostic accuracy and biopsy-related infections. Learn More